Skip to main content
Jaleh Fallah, MD, Oncology, Silver Spring, MD

JalehFallahMD

Oncology Silver Spring, MD

Genitourinary Oncology

Hematology and Medical Oncology

Dr. Fallah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fallah's full profile

Already have an account?

  • Office

    10903 New Hampshire Ave
    Silver Spring, MD 20903

Summary

  • Hematology and Medical Oncology
  • Correlation of myeloid-derived suppressor cells (MDSC) with pathologic complete

    Background: MDSCs play an important role in maintaining a tumor immunosuppressive microenvironment. The association of circulating levels of MDSCs with pCR (pT0

    Neoadjuvant durvalumab +/- tremelimumab affects the expression of immune checkpo

    Background: In a single arm, open label phase 1b clinical trial the safety of neoadjuvant durvalumab +/- tremelimumab was studied in pts with (w) locally advanc

    https://link.springer.com/epdf/10.1007/s11912-019-0752-z?author_access_token=ENu

    Jaleh Fallah - Hematology/Oncology fellow - Cleveland Clinic | LinkedIn

    View Jaleh Fallah's profile on LinkedIn.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2017 - 2020
  • Brown University
    Brown UniversityResidency, Internal Medicine, 2014 - 2017
  • Isfahan University of Medical Sciences
    Isfahan University of Medical SciencesClass of 2010

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2017 - 2025
  • RI State Medical License
    RI State Medical License 2014 - 2017
  • MA State Medical License
    MA State Medical License 2015 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • ASCO Trainee Council Member 2019-2021
  • 16th Annual AAADV Workshop Travel Scholarship 2019
  • AACR associate member 2019
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The role of immunotherapy in the management of patients with renal cell carcinoma and brain metastases  
    Jaleh Fallah, Manmeet S. Ahluwalia, Annals of Translational Medicine (ATM), 10/2019
  • Relationship between negative affectivity and severity of irritable bowel syndrome (IBS) symptoms  
    Bagherian-Sararoudi R, Kalantari H, Afshar H, Daghaghzadeh H, Abotalebian F, Falah J, Adibi P, Journal of Babol University of Medical Sciences

Abstracts/Posters

  • Circulating cell-free DNA (cfDNA) levels and fragmentation pattern can distinguish nonmuscle invasive (NMI) from muscle-invasive (MI) and metastatic (met) bladder canc...
    Jaleh Fallah, Shinjini Ganguly, Hong Li, Wei (Auston) Wei, Aysegul Balyimez, Thirunavukkarasu Sitalaximi, C. Marcela Diaz-Montero, Patricia A. Rayman, Marcelo Lamenza,..., Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 4523-4523.ASCO Annual Meeting 2019, Chicago, IL, 6/2019
  • Association of cell-free DNA (cfDNA) levels with myeloid-derived suppressor cells (MDSC) levels in blood of patients (pts) with muscle invasive (MI) and metastatic (me...
    Jaleh Fallah, Shinjini Ganguly, Patricia A. Rayman, Wei (Auston) Wei, Aysegul Balyimez, Thirunavukkarasu Sitalaximi, Marcelo Lamenza, Kevin L. Stephans, Priscilla Dann..., Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 4528-4528. ASCO Annual Meeting 2019., Chicago, IL, 6/2019
  • Neoadjuvant durvalumab +/-tremelimumab affects the expression of immune checkpoint molecules on myeloid derived suppressor cells in patients with locally advanced rena...
    Fallah J, Diaz-Montero CM, Rayman P, Wei W, Wood L, Martin A, Allman K, Gilligan T, Ornstein M, Garcia JA, Rini BI, GU-ASCO 2019 (Genitourinary Cancers Symposium), San Francisco, CA, 1/1/2019
  • Join now to see all

Lectures

  • Circulating cell-free DNA (cfDNA) levels and fragmentation pattern can distinguish nonmuscle invasive (NMI) from muscle-invasive (MI) and metastatic (met) bladder canc... 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • Association of cell-free DNA (cfDNA) levels with myeloid-derived suppressor cells (MDSC) levels in blood of patients (pts) with muscle invasive (MI) and metastatic (me... 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • Journal Club: Superiority clinical trial design 
    Cleveland Clinic, Taussig Cancer Institute - 11/15/2019
  • Join now to see all

Authored Content

  • The Importance of Myeloid-Derived Suppressor Cells in Oncology - Beyond the AbstractMay 2020

Press Mentions

  • Second-Generation Androgen Receptor Inhibitors Supported for Older Nonmetastatic CRPC Patients
    Second-Generation Androgen Receptor Inhibitors Supported for Older Nonmetastatic CRPC PatientsFebruary 8th, 2021
  • Targeting the Sanctuary Site: Options When Breast Cancer Metastasizes to the Brain
    Targeting the Sanctuary Site: Options When Breast Cancer Metastasizes to the BrainAugust 23rd, 2019
  • Don’t Miss These Cleveland Clinic Cancer Center Presentations at the 2019 ASCO Annual Meeting
    Don’t Miss These Cleveland Clinic Cancer Center Presentations at the 2019 ASCO Annual MeetingMay 30th, 2019
  • Join now to see all

Committees

  • Review editor, Frontiers in Oncology - Genitourinary Oncology

Professional Memberships

Other Languages

  • Farsi